Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial

The British Journal of Psychiatry : the Journal of Mental Science
Amanda L BakerVaughan J Carr

Abstract

Few randomised controlled trials have been aimed specifically at substance use reduction among people with psychotic disorders. To investigate whether a 10-session intervention consisting of motivational interviewing and cognitive-behavioural therapy (CBT) was more efficacious than routine treatment in reducing substance use and improving symptomatology and general functioning. A community sample of people with a psychotic disorder and who reported hazardous alcohol, cannabis and/or amphetamine use during the preceding month was recruited. Participants were randomly allocated to motivational interviewing/CBT (n = 65) or treatment as usual (n = 65), and were assessed on multiple outcomes at baseline, 15 weeks, 6 months and 12 months. There was a short-term improvement in depression and a similar trend with regard to cannabis use among participants who received the motivational interviewing/CBT intervention, together with effects on general functioning at 12 months. There was no differential benefit of the intervention on substance use at 12 months, except for a potentially clinically important effect on amphetamine use. The motivational interviewing/CBT intervention was associated with modest improvements.

References

Jan 1, 1989·British Journal of Addiction·C R Schuster
Jun 1, 1995·Drug and Alcohol Dependence·J W CornishC P O'Brien
Sep 25, 1998·The British Journal of Psychiatry : the Journal of Mental Science·R KempA David
Feb 13, 1999·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·J Jamieson
May 2, 2000·The Australian and New Zealand Journal of Psychiatry·A JablenskyC Harvey
Sep 12, 2001·The Australian and New Zealand Journal of Psychiatry·C M LoughlandT J Lewin
Sep 12, 2001·Journal of Substance Abuse Treatment·J CopelandR Stephens
Nov 10, 2001·BMJ : British Medical Journal·A J Vickers, D G Altman
Jan 5, 2002·Drug and Alcohol Dependence·Van L KingRobert K Brooner
Oct 9, 2002·Addictive Behaviors·Gerard M SchippersJan A Walburg
Nov 20, 2002·The British Journal of Clinical Psychology·Mike StartupSue Bendix
Dec 6, 2002·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Robert C. SmithAntonis Kotsaftis
Feb 13, 2003·Journal of Clinical Psychology·Forrest R ScoginDouglas Welsh
Sep 25, 2003·Journal of Clinical Epidemiology·C C Wright, J Sim
Nov 5, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Gillian HaddockShôn Lewis
Mar 23, 2004·Behaviour Research and Therapy·Andrew J Baillie, Ronald M Rapee
Apr 20, 2004·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·John Jamieson
Jan 1, 1992·Drug and Alcohol Review·R G Pols, D V Hawks

❮ Previous
Next ❯

Citations

Sep 28, 2013·Translational Behavioral Medicine·Sacha L FiliaJill M Williams
Dec 9, 2009·Journal of Consulting and Clinical Psychology·Clara M BradizzaNicole D Mercer
Dec 4, 2009·Schizophrenia Bulletin·Lisa B DixonUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Apr 2, 2009·International Journal of Nursing Practice·Karen-Leigh Edward, Ian Munro
Sep 17, 2010·Psychiatry Research·Madeleine deVilleCarmel Loughland
Jul 14, 2010·Issues in Mental Health Nursing·Anthony P O'BrienKuei-Ro Chou
May 14, 2011·Nordic Journal of Psychiatry·Freddy SarinBirgitta Widerlöv
May 30, 2012·The Psychiatric Clinics of North America·Itai Danovitch, David A Gorelick
Dec 27, 2011·Addictive Behaviors·Louise K ThorntonMartin P Johnson
Jul 26, 2008·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Euphrosyne Gouzoulis-Mayfrank
Feb 10, 2007·Psychiatry Research·Amanda BakerKristen Moeller-Saxone
Oct 20, 2006·Schizophrenia Research·Carmel M LoughlandAnthony W Harris
Dec 19, 2006·Journal of Substance Abuse Treatment·James Shearer
Jun 19, 2015·Drug and Alcohol Review·Louisa DegenhardtGeorge Patton
Aug 1, 2008·International Journal of Mental Health Nursing·Ian Munro, Karen-Leigh Edward
Apr 15, 2014·The American Journal on Addictions·Hong-Qiang SunThomas R Kosten
Apr 14, 2016·Schizophrenia Research·Shane RebgetzLeanne Hides
Mar 31, 2015·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN WFSBP Task Force on Treatment Guidelines for Schizophrenia
Mar 7, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Amanda L BakerNatasha Weaver
Jan 1, 2013·Drug and Alcohol Dependence·Frank N AngeloRichard Ries
Oct 8, 2016·The American Journal of Drug and Alcohol Abuse·Melanie E BennettLauren T Catalano
Jun 8, 2011·Psychotherapy and Psychosomatics·Charles BonsackPhilippe Conus
Jun 3, 2016·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Cristina AydinZenovia Ursuliak
Apr 28, 2007·The Australian and New Zealand Journal of Psychiatry·Daren M DraganicVaughan J Carr
May 18, 2007·The Australian and New Zealand Journal of Psychiatry·Adrian C BradleyTerry J Lewin
Oct 10, 2007·The Australian and New Zealand Journal of Psychiatry·Sarah E Flanders
Sep 14, 2007·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Rosalind KempThiagarajan Sitharthan
Feb 21, 2018·Journal of Dual Diagnosis·J ChiltonP J Tyson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.